Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

644 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia.
Chen LS, Bose P, Cruz ND, Jiang Y, Wu Q, Thompson PA, Feng S, Kroll MH, Qiao W, Huang X, Jain N, Wierda WG, Keating MJ, Gandhi V. Chen LS, et al. Among authors: bose p. Blood. 2018 Nov 22;132(21):2249-2259. doi: 10.1182/blood-2018-06-860593. Epub 2018 Sep 25. Blood. 2018. PMID: 30254130 Free PMC article. Clinical Trial.
Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial.
Jain P, Keating M, Renner S, Cleeland C, Xuelin H, Gonzalez GN, Harris D, Li P, Liu Z, Veletic I, Rozovski U, Jain N, Thompson P, Bose P, DiNardo C, Ferrajoli A, O'Brien S, Burger J, Wierda W, Verstovsek S, Kantarjian H, Estrov Z. Jain P, et al. Among authors: bose p. Lancet Haematol. 2017 Feb;4(2):e67-e74. doi: 10.1016/S2352-3026(16)30194-6. Epub 2017 Jan 12. Lancet Haematol. 2017. PMID: 28089238 Free PMC article. Clinical Trial.
Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex.
Rozovski U, Harris DM, Li P, Liu Z, Jain P, Veletic I, Ferrajoli A, Burger J, O'Brien S, Bose P, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z. Rozovski U, et al. Among authors: bose p. Mol Cancer Res. 2017 May;15(5):610-618. doi: 10.1158/1541-7786.MCR-16-0291. Epub 2017 Jan 27. Mol Cancer Res. 2017. PMID: 28130399 Free PMC article.
Pathways and mechanisms of venetoclax resistance.
Bose P, Gandhi V, Konopleva M. Bose P, et al. Leuk Lymphoma. 2017 Sep;58(9):1-17. doi: 10.1080/10428194.2017.1283032. Epub 2017 Jan 31. Leuk Lymphoma. 2017. PMID: 28140720 Free PMC article. Review.
Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia.
Abou Zahr A, Bose P, Keating MJ. Abou Zahr A, et al. Among authors: bose p. Expert Opin Pharmacother. 2017 Jun;18(9):857-873. doi: 10.1080/14656566.2017.1324420. Epub 2017 May 16. Expert Opin Pharmacother. 2017. PMID: 28446054 Free PMC article. Review.
Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuation.
Newberry KJ, Patel K, Masarova L, Luthra R, Manshouri T, Jabbour E, Bose P, Daver N, Cortes J, Kantarjian H, Verstovsek S. Newberry KJ, et al. Among authors: bose p. Blood. 2017 Aug 31;130(9):1125-1131. doi: 10.1182/blood-2017-05-783225. Epub 2017 Jul 3. Blood. 2017. PMID: 28674026 Free PMC article.
Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma.
Abaza Y, M Kantarjian H, Faderl S, Jabbour E, Jain N, Thomas D, Kadia T, Borthakur G, D Khoury J, Burger J, Wierda W, O'Brien S, Konopleva M, Ferrajoli A, Kebriaei P, Dabaja B, Kornblau S, Alvarado Y, Daver N, Pemmaraju N, Bose P, Thompson P, Al Azzawi H, Kelly M, Garris R, Jain P, Garcia-Manero G, Cortes J, Ravandi F. Abaza Y, et al. Among authors: bose p. Am J Hematol. 2018 Jan;93(1):91-99. doi: 10.1002/ajh.24947. Epub 2017 Nov 3. Am J Hematol. 2018. PMID: 29047158 Free article.
644 results